Cargando…

Very Low Alcohol Consumption Is Associated with Lower Prevalence of Cirrhosis and Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease

The role of moderate alcohol consumption in the evolution of NAFLD is still debated. The aim of this study is to evaluate the impact of current and lifelong alcohol consumption in patients with NAFLD. From 2015 to 2020, we enrolled 276 consecutive patients fulfilling criteria of NAFLD (alcohol consu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferri, Silvia, Stefanini, Bernardo, Mulazzani, Lorenzo, Alvisi, Margherita, Tovoli, Francesco, Leoni, Simona, Muratori, Luca, Lotti, Tommaso, Granito, Alessandro, Bolondi, Luigi, Piscaglia, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231078/ https://www.ncbi.nlm.nih.gov/pubmed/35745223 http://dx.doi.org/10.3390/nu14122493

Ejemplares similares

Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis
por: Leoni, Simona, et al.
Publicado: (2018)

A Relative Deficiency of Lysosomal Acid Lypase Activity Characterizes Non-Alcoholic Fatty Liver Disease
por: Tovoli, Francesco, et al.
Publicado: (2017)

Lung Ultrasound Is Often, but Not Always, Normal in Healthy Subjects: Considerations for COVID-19 Pandemic
por: Raiteri, Alberto, et al.
Publicado: (2021)

Effects of SARS-CoV2 pandemic in a cohort of italian NAFLD patients
por: Stefanini, Bernardo, et al.
Publicado: (2022)

Autoantibodies to speckled protein family in primary biliary cholangitis
por: Granito, Alessandro, et al.
Publicado: (2021)

A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption
por: Mancina, Rosellina Margherita, et al.
Publicado: (2019)

Prognosis of Single Early-Stage Hepatocellular Carcinoma (HCC) with CEUS Inconclusive Imaging (LI-RADS LR-3 and LR-4) Is No Better than Typical HCC (LR-5)
por: Terzi, Eleonora, et al.
Publicado: (2022)

Imaging findings of hepatic epithelioid hemangioendothelioma and fibrolamellar hepatocellular carcinoma: a critical appraisal of current literature about imaging features of two rare liver cancers
por: Mulazzani, Lorenzo, et al.
Publicado: (2019)

New Diagnostic and Prognostic Models for the Development of Alcoholic Cirrhosis Based on Genetic Predisposition and Alcohol History
por: Mischitelli, Monica, et al.
Publicado: (2023)

Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular Carcinoma
por: Ielasi, Luca, et al.
Publicado: (2023)

Association of fibroblast growth factor 21 with alcohol consumption and alcohol liver cirrhosis
por: Wagner-Skacel, Jolana, et al.
Publicado: (2020)

Metronomic Capecitabine in Patients With Hepatocellular Carcinoma Unresponsive to or Ineligible for Sorafenib Treatment: Report of Two Cases
por: Marinelli, Sara, et al.
Publicado: (2013)

Celiac Disease Diagnosed through Screening Programs in At-Risk Adults Is Not Associated with Worse Adherence to the Gluten-Free Diet and Might Protect from Osteopenia/Osteoporosis
por: Tovoli, Francesco, et al.
Publicado: (2018)

Differences in Fecal Short-Chain Fatty Acids between Alcoholic Fatty Liver-Induced Cirrhosis and Non-alcoholic (Metabolic-Associated) Fatty Liver-Induced Cirrhosis
por: Cao, Xinlu, et al.
Publicado: (2023)

Alcohol and Cirrhosis
Publicado: (1898)

Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC
por: Granito, Alessandro, et al.
Publicado: (2021)

COVID-19: Has the Liver Been Spared?
por: Brandi, Nicolò, et al.
Publicado: (2023)

Effects of Moderate Alcohol Consumption in Non-Alcoholic Fatty Liver Disease
por: Lemmer, Peter, et al.
Publicado: (2022)

The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
por: Oh, Hyunwoo, et al.
Publicado: (2023)

Liver Cirrhosis in Alcoholics
por: Demeulenaere, L., et al.
Publicado: (1977)

Liver cirrhosis mortality, alcohol consumption and tobacco consumption over a 62 year period in a high alcohol consumption country: a trend analysis
por: John, Ulrich, et al.
Publicado: (2015)

PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis
por: Burza, Maria Antonella, et al.
Publicado: (2014)

Effects of COVID-19 Pandemic on Metabolic Status and Psychological Correlates of a Cohort of Italian NAFLD Outpatients
por: Ferri, Silvia, et al.
Publicado: (2023)

Evidence for involvement of the alcohol consumption WDPCP gene in lipid metabolism, and liver cirrhosis
por: O’Farrell, Felix, et al.
Publicado: (2023)

Alcohol consumption and alcohol policy
por: İLHAN, Mustafa Necmi, et al.
Publicado: (2020)

Diabetes Mellitus Predicts Occurrence of Cirrhosis and Hepatocellular Cancer in Alcoholic Liver and Non-alcoholic Fatty Liver Diseases
por: Raff, Evan J., et al.
Publicado: (2015)

Alcohol Policies and Alcoholic Cirrhosis Mortality in the United States
por: Hadland, Scott E., et al.
Publicado: (2015)

The clinical course of alcoholic cirrhosis: effects of hepatic metabolic capacity, alcohol consumption, and hyponatremia – a historical cohort study
por: Jepsen, Peter, et al.
Publicado: (2012)

Clinical Significance of Gamma-Glutamyltranspeptidase Combined with Carbohydrate-Deficient Transferrin for the Assessment of Excessive Alcohol Consumption in Patients with Alcoholic Cirrhosis
por: Shibamoto, Akihiko, et al.
Publicado: (2021)

Frailty in Nonalcoholic Fatty Liver Cirrhosis: A Comparison with Alcoholic Cirrhosis, Risk Patterns, and Impact on Prognosis
por: Skladany, Lubomir, et al.
Publicado: (2021)

Experience with regorafenib in the treatment of hepatocellular carcinoma
por: Granito, Alessandro, et al.
Publicado: (2021)

Role of Alcohol in the Pathogenesis of Cirrhosis
por: Klatskin, Gerald
Publicado: (1953)

Medical Treatment of Hepatocellular Carcinoma
por: Granito, Alessandro, et al.
Publicado: (2009)

Rare leptin in non-alcoholic fatty liver cirrhosis: A case report
por: Nong, Yao-Bin, et al.
Publicado: (2022)

Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases
por: Safaei, Akram, et al.
Publicado: (2016)

Evaluation of hepatitis A, B, and C serology in patients with cirrhosis and intensive alcohol consumption
por: Vatansever, Sezgin, et al.
Publicado: (2018)

Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease
por: Patel, Preya J., et al.
Publicado: (2017)

Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease
por: ter Horst, Kasper W., et al.
Publicado: (2017)

Egg consumption and risk of non-alcoholic fatty liver disease
por: Mokhtari, Zeinab, et al.
Publicado: (2017)

Alcohol consumption in patients with nonalcoholic fatty liver disease: yes, or no?
por: Protopapas, Adonis A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2efdn373vo0qk4g0nm32fvupi8